Gerhard Johann Frey

This inventor holds 87 USPTO granted patents and 42 published patent applications, plus 16 CIPO patents and 34 EPO patents, primarily in Antibody Therapeutics (CPC class C07K2317-24). Top assignees: Bioatla, Inc., Novartis Ag, Verenium Corporation. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Johann Frey. Retrieved from https://idiyas.com/inventor/gerhard-johann-frey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 87 (Patent Applications = 42)

% Patents Active = 81.6

CIPO Patents = 16 (Patent Applications = 23)

EPO Patents = 34 (Patent Applications = 60)

Average Co-Inventor Count = 3.8

ph-index = 17

Forward Citations = 930(Granted Patents)

Forward Citations (Not Self Cited) = 808(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

St. Louis, MO (US) (2020)
San Diego, CA (US) (2001 - 2024)

Company Filing History:

Dana-Farber-Cancer Institute Inc.

Syngenta Participations Ag

Corvus Pharmaceuticals, Inc.

patents

13. 2 out of 2

Femta Pharmaceuticals, Inc.

Tioma Therapeutics, Inc.

patents

16. 2 out of 2,663

University of Pennsylvania

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Antibody Molecules

Chimeric Antigen Receptors

Multi-Specific Antibodies

Anti-PD-L1

Anti-CTLA4

Anti-AXL

Anti-ROR2

Conditionally Active Proteins

Immunoconjugates

Cancer Therapy

Therapeutic Antibodies

87 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12742020 - CHIMERIC ANTIGEN RECEPTORS TO HER2 AND METHODS OF USE THEREOF (2026-09-22),

2. 12649793 - ANTI-CTLA4 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof (2026-06-09),

3. 12600777 - COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 (2026-04-14),

4. 12473360 - MULTI-SPECIFIC ANTIBODY CONSTRUCTS (2025-11-18),

5. 12427347 - Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof (2025-09-30),

6. 12311032 - Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof (2025-05-27),

7. 12252535 - Antibody molecules to LAG-3 and uses thereof (2025-03-18),

8. 12187801 - Chimeric antigen receptors against AXL or ROR2 and methods of use thereof (2025-01-07),

9. 12186278 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2025-01-07),

10. 12110611 - Conditionally active biological proteins (2024-10-08),

11. 11897959 - Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof (2024-02-13),

12. 11879011 - Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof (2024-01-23),

13. 11859007 - Humanized anti-CD73 antibodies (2024-01-02),

14. 11851499 - Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof (2023-12-26),

15. 11834472 - Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof (2023-12-05),

Title: Gerhard Johann Frey: Pioneering Inventor from San Diego

Introduction: Gerhard Johann Frey is a renowned inventor based in San Diego, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Gerhard Johann Frey holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, with his most recent patent focusing on advanced robotics for healthcare applications.

Career Highlights: Throughout his illustrious career, Gerhard Johann Frey has worked with leading tech companies to develop innovative solutions that have revolutionized industries. His expertise in merging technology with healthcare has led to significant advancements in patient care.

Collaborations: Gerhard Johann Frey has collaborated with top researchers, engineers, and medical professionals to bring his inventions to life. His ability to work across disciplines has resulted in cutting-edge products that have improved the quality of life for many.

Conclusion: Gerhard Johann Frey's passion for innovation and his dedication to pushing the boundaries of technology make him a standout figure in the world of inventors. His impact on various industries is truly remarkable, and his legacy continues to inspire future generations of inventors.

Profile summary based on public USPTO records.